- Home
- FBRX vs SACH Comparison
FBRX vs SACH Comparison
Compare FBRX & SACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FBRX | SACH |
|---|---|---|
| Founded | N/A | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 253.7M | 52.0M |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | FBRX | SACH |
|---|---|---|
| Price | $21.41 | $1.18 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 3 |
| Target Price | ★ $67.00 | $2.00 |
| AVG Volume (30 Days) | 113.8K | ★ 232.7K |
| Earning Date | 11-14-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 16.95% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $3,906,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.73 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.90 | $0.80 |
| 52 Week High | $25.97 | $1.40 |
Technical Indicators
Market Signals| Indicator | FBRX | SACH |
|---|---|---|
| Relative Strength Index (RSI) | 64.32 | 60.16 |
| Support Level | $18.85 | $1.00 |
| Resistance Level | $21.45 | $1.16 |
| Average True Range (ATR) | 2.00 | 0.05 |
| MACD | 0.14 | 0.02 |
| Stochastic Oscillator | 66.30 | 69.57 |
Price Performance
Historical ComparisonAbout FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).
About SACH Sachem Capital Corp.
Sachem Capital Corp is a real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns majority of its revenue through Interest income from loans.